title: Peripartum cardiomyopathy: a new successful setting for levosimendan.
authors.forename: Juan
authors.initials: J
authors.lastname: Benezet-Mazuecos
authors.forename: Javier
authors.initials: J
authors.lastname: de la Hera
mesh_terms: D000328:Adult; D002316:Cardiotonic Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D049590:Postpartum Period; D011247:Pregnancy; D011724:Pyridazines / Q000008:administration & dosage*; D018570:Risk Assessment; D012720:Severity of Illness Index; D000077464:Simendan; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan